skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Panel Roster

(Last updated: November 13, 2014; last reviewed: November 13, 2014)

Members of Panel on Antiretroviral Guidelines for Adults and Adolescents Panel Roster

These Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents are developed by the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) a Working Group of the Office of AIDS Research Advisory Council (OARAC).
   
Panel Co-Chairs  
 Roy M. Gulick Weill Medical College of Cornell University, New York, NY 
 Martin S. Hirsch
Massachusetts General Hospital & Harvard Medical School, Boston, MA 
 H. Clifford Lane
National Institutes of Health, Bethesda, MD
   
 Executive Secretary
 Alice K. Pau National Institutes of Health, Bethesda, MD
   
 Scientific Members
 Judith Aberg  Icahn School of Medicine of Mount Sinai University, New York, NY
 Adaora Adimora  University of North Carolina, Chapel Hill, NC
 John T. Brooks  Centers for Disease Control and Prevention, Atlanta, GA
 J. Kevin Carmichael  El Rio Specialty Immunology Associates, Tucson, AZ
 Deborah L. Cohan  University of California–San Francisco, San Francisco, CA
 Eric Daar  University of California–Los Angeles, Harbor-UCLA Medical Center, Los Angeles, CA
 Gerald Friedland  Yale University School of Medicine, New Haven, CT
 Rajesh T. Gandhi  Massachusetts General Hospital & Harvard Medical School, Boston, MD
 Stephen J. Gange  Johns Hopkins University, Baltimore, MD
 Thomas Giordano  Baylor College of Medicine, Houston, TX 
 Richard Haubrich  University of California–San Diego, San Diego, CA 
 Michael D. Hughes  Harvard School of Public Health, Boston, MA
 Peter Hunt  University of California–San Francisco, San Francisco, CA 
 Bill G. Kapogiannis  National Institutes of Health, Bethesda, MD
 Marla Keller  Albert Einstein College of Medicine, New York, NY 
 Daniel R. Kuritzkes  Brigham and Women’s Hospital & Harvard Medical School, Boston, MA 
 Jeffrey Lennox  Emory University, Atlanta, GA
 Richard W. Price  University of California–San Francisco, San Francisco, CA
 James L. Raper  University of Alabama at Birmingham, Birmingham, AL
 Bret J. Rudy  New York University, New York, NY
 Paul Sax  Brigham and Women’s Hospital & Harvard Medical School, Boston, MA
 Kimberly Scarsi University of Nebraska, Omaha, NE
 Mark Sulkowski  Johns Hopkins University, Baltimore, MD
 Pablo Tebas  University of Pennsylvania, Philadelphia, PA
 Zelalem Temesgen  Mayo Clinic, Rochester, MN
 Phyllis Tien  University of California–San Francisco, San Francisco, CA
 Rochelle Walensky  Massachusetts General Hospital & Harvard Medical School, Boston, MA
 David A. Wohl  University of North Carolina, Chapel Hill, NC
   
 Community Members
 Lei Chou  Treatment Action Group, New York, NY
 David Evans  Project Inform, San Francisco, CA
 Danielle Houston  Houston, TX
 Jeff Taylor  AIDS Treatment Activists Coalition, Palm Springs, CA
 Nelson Vergel  Program for Wellness Restoration, Houston, TX
   
 Members Representing Department of Health and Human Services Agencies
 Victoria Cargill  National Institutes of Health, Rockville, MD
 Laura Cheever  Health Resources and Services Administration, Rockville, MD
 Rohan Hazra National Institutes of Health, Bethesda, MD
 Jonathan Kaplan   Centers for Disease Control and Prevention, Atlanta, GA
 Kendall Marcus  Food and Drug Administration, Silver Spring, MD
 Henry Masur   National Institutes of Health, Bethesda, MD
 Lynne Mofenson   National Institutes of Health, Bethesda, MD (Membership ended September 2014)
 Kimberly Struble  Food and Drug Administration, Silver Spring, MD
   
 Non-Voting Observer
 James Mikula Leidos Biomedical Research, Inc., in support of National Institute of Allergy and Infectious Diseases

Back to Top